Loading data
VETNYSE
| Unit: CAD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.77 bn CAD | 1.9 bn CAD | 2.01 bn CAD | 3.42 bn CAD | 2.04 bn CAD |
| Cost of revenue | 1.3 bn CAD | 789.62 m CAD | 1.84 bn CAD | 665.06 m CAD | -623.79 m CAD |
| Gross profit | 462.9 m CAD | 1.11 bn CAD | 169.77 m CAD | 2.75 bn CAD | 2.66 bn CAD |
| Selling, general and administrative expense | 90.15 m CAD | 74.01 m CAD | 80.72 m CAD | 57.68 m CAD | 52.88 m CAD |
| Operating profit after depreciation | -396.34 m CAD | 249.4 m CAD | -701.75 m CAD | 2.06 bn CAD | 2 bn CAD |
| Operating profit before depreciation | 372.75 m CAD | 1.01 bn CAD | 89.06 m CAD | 2.69 bn CAD | 2.61 bn CAD |
| EBIT | -396.34 m CAD | 249.4 m CAD | -701.75 m CAD | 2.06 bn CAD | 2 bn CAD |
| EBITDA | 372.75 m CAD | 1.01 bn CAD | 89.06 m CAD | 2.69 bn CAD | 2.61 bn CAD |
| Interest expense | 132.75 m CAD | 84.61 m CAD | 85.21 m CAD | 82.86 m CAD | 73.08 m CAD |
| Profit before tax | -324.82 m CAD | -6.59 m CAD | -278.28 m CAD | 2.05 bn CAD | 1.38 bn CAD |
| Income tax expense | 39.99 m CAD | 40.15 m CAD | -40.7 m CAD | 738.04 m CAD | 233.2 m CAD |
| Income before extraordinary items | -364.81 m CAD | -46.74 m CAD | -237.59 m CAD | 1.31 bn CAD | 1.15 bn CAD |
| Net income (reported basis) | -653.6 m CAD | -46.74 m CAD | -237.59 m CAD | 1.31 bn CAD | 1.15 bn CAD |
| Basic EPS including extraordinary items | -4.25 CAD/share | -0.3 CAD/share | -1.45 CAD/share | 8.03 CAD/share | 7.13 CAD/share |
| Diluted EPS including extraordinary items | -4.25 CAD/share | -0.3 CAD/share | -1.45 CAD/share | 7.8 CAD/share | 6.97 CAD/share |
| Common dividends | 79.91 m CAD | 75.33 m CAD | 65.25 m CAD | 45.77 m CAD | 0 CAD |
| Total dividends | 79.91 m CAD | 75.33 m CAD | 65.25 m CAD | 45.77 m CAD | 0 CAD |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.